Literature DB >> 30912638

A Novel Assay for RNA Polymerase I Transcription Elongation Sheds Light on the Evolutionary Divergence of Eukaryotic RNA Polymerases.

Catherine E Scull1,2, Zachariah M Ingram1,2, Aaron L Lucius2, David A Schneider1.   

Abstract

Eukaryotic cells express at least three nuclear RNA polymerases (Pols), each with a unique set of gene targets. Though these enzymes are homologous, there are many differences among the Pols. In this study, a novel assay for Pol I transcription elongation was developed to probe enzymatic differences among the Pols. In Saccharomyces cerevisiae, a mutation in the universally conserved hinge region of the trigger loop, E1103G, induces a gain of function in the Pol II elongation rate, whereas the corresponding mutation in Pol I, E1224G, results in a loss of function. The E1103G Pol II mutation stabilizes the closed conformation of the trigger loop, promoting the catalytic step, the putative rate-limiting step for Pol II. In single-nucleotide and multinucleotide addition assays, we observe a decrease in the rate of nucleotide addition and dinucleotide cleavage activity by E1224G Pol I and an increase in the rate of misincorporation. Collectively, these data suggest that Pol I is at least in part rate-limited by the same step as Pol II, the catalytic step.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30912638      PMCID: PMC6600827          DOI: 10.1021/acs.biochem.8b01256

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  40 in total

1.  Trigger loop dynamics mediate the balance between the transcriptional fidelity and speed of RNA polymerase II.

Authors:  Matthew H Larson; Jing Zhou; Craig D Kaplan; Murali Palangat; Roger D Kornberg; Robert Landick; Steven M Block
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-09       Impact factor: 11.205

2.  A movie of RNA polymerase II transcription.

Authors:  Alan C M Cheung; Patrick Cramer
Journal:  Cell       Date:  2012-06-22       Impact factor: 41.582

3.  Divergent contributions of conserved active site residues to transcription by eukaryotic RNA polymerases I and II.

Authors:  Olga V Viktorovskaya; Krysta L Engel; Sarah L French; Ping Cui; Paul J Vandeventer; Emily M Pavlovic; Ann L Beyer; Craig D Kaplan; David A Schneider
Journal:  Cell Rep       Date:  2013-08-29       Impact factor: 9.423

4.  A central role of the RNA polymerase trigger loop in active-site rearrangement during transcriptional pausing.

Authors:  Innokenti Toulokhonov; Jinwei Zhang; Murali Palangat; Robert Landick
Journal:  Mol Cell       Date:  2007-08-03       Impact factor: 17.970

5.  Transient reversal of RNA polymerase II active site closing controls fidelity of transcription elongation.

Authors:  Maria L Kireeva; Yuri A Nedialkov; Gina H Cremona; Yuri A Purtov; Lucyna Lubkowska; Francisco Malagon; Zachary F Burton; Jeffrey N Strathern; Mikhail Kashlev
Journal:  Mol Cell       Date:  2008-06-06       Impact factor: 17.970

Review 6.  Structure of eukaryotic RNA polymerases.

Authors:  P Cramer; K-J Armache; S Baumli; S Benkert; F Brueckner; C Buchen; G E Damsma; S Dengl; S R Geiger; A J Jasiak; A Jawhari; S Jennebach; T Kamenski; H Kettenberger; C-D Kuhn; E Lehmann; K Leike; J F Sydow; A Vannini
Journal:  Annu Rev Biophys       Date:  2008       Impact factor: 12.981

7.  Rate-limiting steps in the DNA polymerase I reaction pathway.

Authors:  V Mizrahi; R N Henrie; J F Marlier; K A Johnson; S J Benkovic
Journal:  Biochemistry       Date:  1985-07-16       Impact factor: 3.162

8.  Targeting RNA polymerase I transcription and the nucleolus for cancer therapy.

Authors:  Ross D Hannan; Denis Drygin; Richard B Pearson
Journal:  Expert Opin Ther Targets       Date:  2013-08       Impact factor: 6.902

9.  Rpb9 subunit controls transcription fidelity by delaying NTP sequestration in RNA polymerase II.

Authors:  Celine Walmacq; Maria L Kireeva; Jordan Irvin; Yuri Nedialkov; Lucyna Lubkowska; Francisco Malagon; Jeffrey N Strathern; Mikhail Kashlev
Journal:  J Biol Chem       Date:  2009-05-13       Impact factor: 5.157

10.  Mechanisms of backtrack recovery by RNA polymerases I and II.

Authors:  Ana Lisica; Christoph Engel; Marcus Jahnel; Édgar Roldán; Eric A Galburt; Patrick Cramer; Stephan W Grill
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-29       Impact factor: 11.205

View more
  7 in total

1.  Downstream sequence-dependent RNA cleavage and pausing by RNA polymerase I.

Authors:  Catherine E Scull; Andrew M Clarke; Aaron L Lucius; David Alan Schneider
Journal:  J Biol Chem       Date:  2019-12-16       Impact factor: 5.157

2.  Multi-start Evolutionary Nonlinear OpTimizeR (MENOTR): A hybrid parameter optimization toolbox.

Authors:  Zachariah M Ingram; Nathaniel W Scull; David S Schneider; Aaron L Lucius
Journal:  Biophys Chem       Date:  2021-09-29       Impact factor: 2.352

3.  Transient-state kinetic analysis of multi-nucleotide addition catalyzed by RNA polymerase I.

Authors:  Zachariah M Ingram; David A Schneider; Aaron L Lucius
Journal:  Biophys J       Date:  2021-09-10       Impact factor: 3.699

4.  RNA polymerase I (Pol I) passage through nucleosomes depends on Pol I subunits binding its lobe structure.

Authors:  Philipp E Merkl; Michael Pilsl; Tobias Fremter; Katrin Schwank; Christoph Engel; Gernot Längst; Philipp Milkereit; Joachim Griesenbeck; Herbert Tschochner
Journal:  J Biol Chem       Date:  2020-02-14       Impact factor: 5.157

5.  The N-terminal domain of the A12.2 subunit stimulates RNA polymerase I transcription elongation.

Authors:  Catherine E Scull; Aaron L Lucius; David A Schneider
Journal:  Biophys J       Date:  2021-03-16       Impact factor: 4.033

6.  Defining the divergent enzymatic properties of RNA polymerases I and II.

Authors:  Ruth Q Jacobs; Zachariah M Ingram; Aaron L Lucius; David A Schneider
Journal:  J Biol Chem       Date:  2020-11-24       Impact factor: 5.157

7.  Defining the Influence of the A12.2 Subunit on Transcription Elongation and Termination by RNA Polymerase I In Vivo.

Authors:  Andrew M Clarke; Abigail K Huffines; Yvonne J K Edwards; Chad M Petit; David A Schneider
Journal:  Genes (Basel)       Date:  2021-11-30       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.